Morgan Stanley’s Zai Lab ZLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.78M | Sell |
94,397
-195,308
| -67% | -$3.62M | ﹤0.01% | 4840 |
|
|
2025
Q4 | $5.11M | Buy |
289,705
+169,825
| +142% | +$3.98M | ﹤0.01% | 4149 |
|
|
2025
Q3 | $4.06M | Sell |
119,880
-169,221
| -59% | -$5.83M | ﹤0.01% | 4314 |
|
|
2025
Q2 | $10.1M | Sell |
289,101
-2,345,458
| -89% | -$77.1M | ﹤0.01% | 3430 |
|
|
2025
Q1 | $95.2M | Sell |
2,634,559
-532,387
| -17% | -$16.4M | 0.01% | 1281 |
|
|
2024
Q4 | $82.9M | Buy |
3,166,946
+1,452,589
| +85% | +$40.3M | 0.01% | 1397 |
|
|
2024
Q3 | $41.4M | Buy |
1,714,357
+1,170,543
| +215% | +$22.1M | ﹤0.01% | 2019 |
|
|
2024
Q2 | $9.42M | Buy |
543,814
+279,105
| +105% | +$4.91M | ﹤0.01% | 3370 |
|
|
2024
Q1 | $4.24M | Sell |
264,709
-317,163
| -55% | -$6.68M | ﹤0.01% | 4036 |
|
|
2023
Q4 | $15.9M | Buy |
581,872
+334,531
| +135% | +$8.83M | ﹤0.01% | 3540 |
|
|
2023
Q3 | $6.01M | Buy |
247,341
+5,920
| +2% | +$158K | ﹤0.01% | 3587 |
|
|
2023
Q2 | $6.69M | Sell |
241,421
-93,790
| -28% | -$3.07M | ﹤0.01% | 3533 |
|
|
2023
Q1 | $11.1M | Buy |
335,211
+80,150
| +31% | +$3.08M | ﹤0.01% | 3049 |
|
|
2022
Q4 | $7.83M | Buy |
255,061
+66,489
| +35% | +$2.1M | ﹤0.01% | 3313 |
|
|
2022
Q3 | $6.45M | Sell |
188,572
-57,844
| -23% | -$2.47M | ﹤0.01% | 3445 |
|
|
2022
Q2 | $8.55M | Buy |
246,416
+100,385
| +69% | +$3.54M | ﹤0.01% | 3232 |
|
|
2022
Q1 | $6.42M | Sell |
146,031
-82,026
| -36% | -$3.97M | ﹤0.01% | 3407 |
|
|
2021
Q4 | $14.3M | Buy |
228,057
+68,729
| +43% | +$5.83M | ﹤0.01% | 2518 |
|
|
2021
Q3 | $16.8M | Buy |
159,328
+44,779
| +39% | +$6.43M | ﹤0.01% | 2274 |
|
|
2021
Q2 | $20.3M | Sell |
114,549
-2,088
| -2% | -$336K | ﹤0.01% | 2131 |
|
|
2021
Q1 | $15.6M | Buy |
116,637
+37,755
| +48% | +$5.85M | ﹤0.01% | 2182 |
|
|
2020
Q4 | $10.7M | Sell |
78,882
-46,363
| -37% | -$4.72M | ﹤0.01% | 2448 |
|
|
2020
Q3 | $10.4M | Buy |
125,245
+4,923
| +4% | +$395K | ﹤0.01% | 1990 |
|
|
2020
Q2 | $9.88M | Buy |
120,322
+96,361
| +402% | +$6.52M | ﹤0.01% | 1975 |
|
|
2020
Q1 | $1.23M | Sell |
23,961
-20,938
| -47% | -$1.09M | ﹤0.01% | 3785 |
|
|
2019
Q4 | $1.87M | Sell |
44,899
-67,663
| -60% | -$2.5M | ﹤0.01% | 4097 |
|
|
2019
Q3 | $3.64M | Buy |
112,562
+89,074
| +379% | +$3.06M | ﹤0.01% | 3222 |
|
|
2019
Q2 | $819K | Buy |
23,488
+11,415
| +95% | +$336K | ﹤0.01% | 4333 |
|
|
2019
Q1 | $356K | Buy |
12,073
+4,942
| +69% | +$135K | ﹤0.01% | 4755 |
|
|
2018
Q4 | $166K | Sell |
7,131
-1,871
| -21% | -$34.7K | ﹤0.01% | 5359 |
|
|
2018
Q3 | $175K | Buy |
9,002
+1,411
| +19% | +$30.6K | ﹤0.01% | 5512 |
|
|
2018
Q2 | $176K | Buy |
7,591
+5,307
| +232% | +$114K | ﹤0.01% | 5583 |
|
|
2018
Q1 | $49K | Buy |
2,284
+1,285
| +129% | +$29.2K | ﹤0.01% | 5884 |
|
|
2017
Q4 | $21K | Sell |
999
-2,001
| -67% | -$53.2K | ﹤0.01% | 6064 |
|
|
2017
Q3 | $81K | Buy |
+3,000
| New | +$83.7K | ﹤0.01% | 5630 |
|
Other funds holding ZLAB
RI
RCM
FLSM
ACM
RSCM
CWG
Morgan Stanley's ZLAB Position: Q1 2026 in Review
Morgan Stanley reduced its Zai Lab (ZLAB) stake by 67% in Q1 2026, selling an estimated $3.62M and leaving 94,397 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #4840.
Morgan Stanley first reported a position in ZLAB in Q3 2017 and has held it in 35 quarters since. The position peaked at $95.2M in Q1 2025. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.
- Morgan Stanley held 94,397 shares of Zai Lab worth $1.78M as of Q1 2026.
- Morgan Stanley sold 195,308 Zai Lab shares in Q1 2026, an estimated $3.62M.
- Zai Lab made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4840 holding.
- Morgan Stanley first reported a position in Zai Lab in Q3 2017 and has held it in 35 quarters since.
- Morgan Stanley's Zai Lab position peaked at $95.2M in Q1 2025.
- 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.